UltraSight raised €11M in a Series B round in May 2021. The company is based in Israel. Investors in the round: Atain Specialty Insurance, Weizmann Institute of Science, Yozma Group Korea. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
